Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient, Placebo Controlled Study
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of the study is to evaluate the Fertitonex effects on semen parameters in clinical varicocele patients.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Primary infertility.
• Abnormal semen analysis parameters.
• Clinically evident varicocele confirmed by scrotal duplex.
Locations
Other Locations
Egypt
Menoufia Faculty of Medicine
RECRUITING
Shebin El-kom
Contact Information
Primary
Ammar F Alorabi
ammar.alorabi95@gmail.com
+201067608011
Time Frame
Start Date: 2024-12-01
Estimated Completion Date: 2026-02-01
Participants
Target number of participants: 110
Treatments
Active_comparator: Fertitonex group
Patients in this group will receive Fertitonex which contains L- carnitine L-tartarate 300 mg, L-arginine 241mg, vitamin B6 1.1 mg, vitamin B12 1.7 mcg, vitamin D3 2 mcg, vitamin E 6.5 mg, vitamin C 60 mg, selenium 28 mcg, zinc 7.5 mg, folic acid 300 mcg and CoQ 10 enzyme 7.5 mg in each capsule. The dose will be one capsule twice daily for 3 months.
Placebo_comparator: Placebo group
Patients in this group will receive placebo capsule twice daily for 3 months.
Related Therapeutic Areas
Sponsors
Leads: Menoufia University